Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185796 · ClinicalTrials.gov registry record · Phase 2
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 77
- Enrollment target
NCT00185796: Completed Phase 2 study, sponsored by Stanford University.
NCT00185796 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 77 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185796, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 77 participants
- Enrollment target
Study Summary
To evaluate the feasibility and safety of TLI/ATG conditioning for allogeneic HCT for elderly patients with advanced stage MDS and MPD.
Interventions
- PROCEDURE Total Lymphoid Irradiation (TLI)
- PROCEDURE Anti-Thymocyte Globulin as Conditioning (ATG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2004-07 |
| Est. Completion | 2015-02 |
| Phase | Phase 2 |
What the finished NCT00185796 record still lists
NCT00185796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 2 interventions - of which Total Lymphoid Irradiation (TLI) is the first listed.
NCT00185796 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00185796 about?
NCT00185796 is a clinical study titled "TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD". To evaluate the feasibility and safety of TLI/ATG conditioning for allogeneic HCT for elderly patients with advanced stage MDS and MPD.
What is the current status of trial NCT00185796?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 77 participants. The study started on 2004-07. Estimated completion is 2015-02.
What interventions are being tested in trial NCT00185796?
The interventions under investigation include: Total Lymphoid Irradiation (TLI) (PROCEDURE), Anti-Thymocyte Globulin as Conditioning (ATG) (PROCEDURE).
Who is sponsoring clinical trial NCT00185796?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00185796's enrollment target sits among peer trials
77 891st of 2000 higher than 1,108 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia